Work

Preclinical studies of the anti-tumor effects of novel Avian paramyxovirus 4 (APMV-4) oncolytic viral therapy combined with vascular endothelial growth factor-C (VEGF-C) in melanoma.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.e15050

Authors: Ruben Fernandez-Rodriguez, Sara Cuadrado-Castano, Aryana Javaheri, Yonina Bykov, Andrew Edwards, Ignacio Mena, Noelia Dasilva-Freire, Anita Rogic, Alice O. Kamphorst, Rosa Karlic, Amir Horowitz, Adolfo García-Sastre, Mihaela Skobe

Institutions: Icahn School of Medicine at Mount Sinai, University of Zagreb, Tisch Cancer Institute

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4286298420

Cites:

Cited by:

Related to: 10